Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I didn't realize the increase of shares a/s from 750m as of 09/30/21 to 2.5Bas of now. When has this been communicated?
With r/s of 1.5, they are barely trading over $ 1,-. That's not good....
Will they get the Nasdaq listing-approval first and then do the r/s or the other way round: they need to do the r/s to get the approval?
LJ: Your calculation is based on r/s between 1:100 and 1:300.
Quote from their 10-Q:
11. SUBSEQUENT EVENTS
Information Statement
On November 29, 2021, the Company filed an Information Statement with the SEC for the holders of record of the outstanding common stock, informing them of the actions to be effective at least 20 days after the mailing of the Information Statement. Contemplated actions are:
A reverse stock split of the Company’s issued and outstanding shares of Common Stock (the “Reverse Stock Split”) with a ratio within the range of 1-for-300 to 1-for-400 (the “Reverse Stock Split Ratio”)
A decrease in the number of authorized shares of Common Stock from 800,000,000 shares to 250,000,000 shares.
The filing of an amendment to our Articles of Incorporation, as amended, to affect the Reverse Stock Split and the Decrease in Authorized Shares.
Amendment to the Unique 2020 Equity and Incentive Plan (the “2020 Plan”) to set the number of shares of the Company’s Common Stock available for issuance under the 2020 Plan to 1,500,000 shares effective upon the Reverse Stock Split.
call him !
Another 50m shares -- outch!!!
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ?
CALCULATION OF REGISTRATION FEE
Title of Each Class of Securities To Be Registered Proposed Maximum Aggregate Offering Price (1)
Amount of Registration
Fee
Common stock, $0.001 par value per share(2)(3) $ 46,000,000 $ 3,800.70
Representatives’ Warrant to Purchase Common Stock (4)
Common Stock to be sold by Selling Stockholders (5) $ 1,000,000 $ 92.7
Shares of Common Stock issuable upon exercise of Representatives’ Warrant (2)(6) $ 3,075,000 $ 285
Total $ 50,075,000 $ 4,178.40 (7)
(1) Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”)
(2) Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of additional shares of common stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.
(3) Includes shares of common stock which may be issued upon exercise of a 45-day option granted to the underwriters to cover over-allotments, if any, equal to 15% of the number of shares sold in the offering.
(4) In accordance with Rule 457(g) under the Securities Act, because the shares of the Registrant’s common stock underlying the Representative’s warrants are registered hereby, no separate registration fee is required with respect to the warrants registered hereby.
(5) Includes 25,000,000 shares of common stock being sold to the underwriters by the selling stockholders. In accordance with Rule 457(c) under the Securities Act, the aggregate offering price for the shares to be sold by the selling stockholders is calculated based on the $0.02 average of the high and low prices reported on the OTC Pink Sheets for January 14, 2022.
(6) The Underwriter’s Warrants are exercisable at a per share exercise price equal to 150% of the public offering price per share of common stock. The proposed maximum aggregate offering price of the Representatives’ Warrants is $3,075,000, which is equal to 150% of $2,050,000 (5% of $8,000,000 which is the maximum offering price without including the over-allotment option).
(7) $3,800.70 previously paid.
r/s between 1:300 and 1:400
What do you expect? The lower level or rather the upper level?
11. SUBSEQUENT EVENTS
Information Statement
On November 29, 2021, the Company filed an Information Statement with the SEC for the holders of record of the outstanding common stock, informing them of the actions to be effective at least 20 days after the mailing of the Information Statement. Contemplated actions are:
A reverse stock split of the Company’s issued and outstanding shares of Common Stock (the “Reverse Stock Split”) with a ratio within the range of 1-for-300 to 1-for-400 (the “Reverse Stock Split Ratio”)
A decrease in the number of authorized shares of Common Stock from 800,000,000 shares to 250,000,000 shares.
The filing of an amendment to our Articles of Incorporation, as amended, to affect the Reverse Stock Split and the Decrease in Authorized Shares.
Amendment to the Unique 2020 Equity and Incentive Plan (the “2020 Plan”) to set the number of shares of the Company’s Common Stock available for issuance under the 2020 Plan to 1,500,000 shares effective upon the Reverse Stock Split.
Amended Securities Exchange Agreement
On December 10, 2021, Unique Logistics International, Inc. (the “Company”) entered into an amended securities exchange agreement (the “Amended Exchange Agreement”) with two investors holding convertible notes, issued by the Company, in the aggregate remaining principal amount of $3,861,160 plus interest; and warrants to purchase an aggregate of 1,140,956,904 shares of common stock of the Company (the “Surrendered Securities”). Pursuant to the Amended Exchange Agreement, the Company agreed to issue, and the Holders agreed to acquire, in exchange for the Surrendered Securities shares of the newly created Series C Convertible Preferred Stock, par value $0.001 per share (the “Series C Preferred”) and shares of Series D Convertible Preferred Stock, par value $0.001 per share (the “Series D Preferred”, and together with the Series C Preferred, the “Preferred Stock”), of the Company, upon entering into the Exchange Amendment.
In connection with the Amended Exchange Agreement, each of the Holders received that certain number of Preferred Stock equal to one share of Preferred Stock for every $10,000.00 of Note Value held by such Holder (the “Exchange Ratio”). Specifically, the Company issued approximately 194.66 shares of Series C Preferred and issued approximately 191.45 shares of Series D Preferred. In the aggregate, each of the Series C Preferred and Series D Preferred may be converted up to an amount of common stock equal to 12.48% of the Company’s capital stock on a fully diluted basis, subject to adjustment. The designations, rights, preferences, and privileges of the Series C Preferred and Series D Preferred are further described below (the “CODs”).
F-24
Upon effectiveness of the Amended Exchange Agreement, the Company no longer has any outstanding convertible notes or warrants.
Series C and D Preferred
The Company has designated 200 shares of preferred stock, $0.001 par value per share, for each of the Series C Preferred and Series D Preferred. The holders of the Preferred Stock shall be entitled to receive, upon liquidation, dissolution or winding up of the Company, the amount of cash, securities or other property to which such holder would be entitled to receive with respect to such shares of Preferred Stock if such shares had been converted to common stock immediately prior to such liquidation.
Holders of the Preferred Stock shall have no voting rights. However, as long as any shares of Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the holders of a majority of the then outstanding series of Preferred Stock, (a) disproportionally alter or change adversely the powers, preferences or rights given to the Preferred Stock or alter or amend the CODs, (b) amend its certificate of incorporation or other charter documents in any manner that disproportionally adversely affects any rights of the holders of the Preferred Stock, (c) increase or decrease the number of authorized shares of each series of Preferred Stock or (d) enter into any agreement with respect to any of the foregoing.
Repayment of Notes Payable
On January 7, 2022, the Company repaid in full both subordinated notes issued on October 1, 2021 per Purchase Agreement with Trillium Partners LP and Carpathia LLC (each a “Buyer”) pursuant to which the Company issued to each Buyer a Note in the aggregate principal amount of $1,000,000, respectively, for a total of $2,000,000 (collectively the “Notes”). The Company also paid a minimum interest payment of $90,000 on each Note and indebtedness was satisfied in full.
Amended and Restated Promissory Note
On April 7, 2021, the Company entered into an Amended and Restated Promissory Note (the “Amended and Restated Note”) with Trillium Partners (“Trillium”), pursuant to which the Company and Trillium amended and restated in its entirety that certain promissory note, issued to Trillium on March 19, 2020 (the “Original Note”). The Amended and Restated Note was to mature on June 15, 2021 (the “Maturity Date”). On September 23, 2021, the Company further amended the Amended and Restated Note pursuant to which the Company and Trillium agreed to extend the maturity date of the Amended and Restated Note to December 31, 2021. On January 6, 2022, the Company entered into a third amendment to the Amended and Restated Note pursuant to which the Company and Trillium agreed to extend the maturity date of the Amended and Restated Note to March 31, 2022.
Weighted average common shares outstanding as of November 30, 2021
– basic 1,764,049,961
– diluted 10,899,465,407
$4.5m divided by 656m shares gives EPS of $.007 (not $ .07).
Better calculate on a fully diluted basis: 10 Billion shares.
Strange price action today on highest volume ever. Maybe next quarterly report will again show a nice surprise.....
I like this little company: strong sales growth, no toxic debt.
Reverse split 1:5 soon...
...see 8-K filed Dec. 17,2021
$ 54m cash per 09/30 and they sell notes over and over?
Smells fishy!!!!
Did they get the first down payment on that $ 3.5B contract?
IB won't execute buy orders in TPTW anymore, only sell orders. Anyone else has this problem?
Don't forget that contract for $3.5 Billion lol lol lol
When I saw the price action, I actually thought we received the first part of that $ 3.5B :):):)
Did they receive the first downpayment on that $ 3.5B order?
I've been told, that companys don't ave to be pink current, pink limited is good enogh to continue trading.
Only pink no information will be taken off the shelves.
When will TPTW receive the first payment on that $3.5B-contract?
When will TPTW receive the first payment an that $3.5B-contract?
Any indication, when the first part of that 3.5B will be in TPTW's pockets?
Pink Limited Information: Will they still be tradeabe following the SEC ruling?
EBITDA and EBIT --- good
fully diluted 10 Billion shares --- not good
Hmmm....did anyone of you take a lokk at the GDP of Ghana?....just aking.....
when do you expect the first upfront payment?
Just trying to figure out, why the share price ist still so low....
I understand its $ 3.5 Billion over a period of 5 years. But is 2022 the first year for sure or could it be 20022?
Telidyne Announces Acquisition of OutSquare MD, Inc.
Telidyne, Inc. (the “Company”) (OTC: TLDN) announced that it has completed the acquisition of OutSquare MD, Inc., (“Outsquare”). Outsquare is a technology company that provides software solutions to virtualize healthcare for patients and doctors. It is also developing several cutting edge softwares and technologies. Further information about Outsquare, now a wholly owned subsidiary of the Company can be obtained from its website at: https://www.outsquaremd.com
In connection with this acquisition, the Company issued 6,480,000 shares of common stock valued at $1.55 per share to the owners of Outsquare, which increased the Company’s total outstanding shares to 12,180,265 shares. After the acquisition, the Company changed its officers and directors. Faisal Mirza has been appointed the CEO and Director, Feroz Shaikh has been appointed the CFO and Director and Paulson Ambookan has been appointed the Company Secretary and Director.
Forward-looking Statements
This press release contains “forward-looking statements.” Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified. Consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210729006127/en/
Telidyne, Inc.
Paulson Ambookan: Paulsona@telidyne.com
Gapping down today?
I sold most of my shares in April above $.10
May be its time to buy again?
Cash of $3.66/share and trading at $4.20.....
They need to show some profit.
PE of 3,3
$ 1.65 cash/share and....
...trading at $ 2.65!!!
Unbelieveable!!!!
This POS is so undervalued.... how come nobody is buying?
and we are talking about up to 250m shares, while shares o/s now are less than 150m
correct, but they will hit the market sooner or later....
Form 253G2 filed yesterday evening
Not 20m shares, but $20m!!! 250m shares....
Could WETH be on Biden's China list?